Viewing Study NCT06722235


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-01-04 @ 2:54 AM
Study NCT ID: NCT06722235
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module